Aug Therapeutics
Clinical trials sponsored by Aug Therapeutics, explained in plain language.
-
Hope for kids with rare 'sticky blood' disease: new drug enters final testing
Disease control Recruiting nowThis study tests an experimental drug called AVTX-803 in people with leukocyte adhesion deficiency type II (LAD II), a rare genetic condition that weakens the immune system and leads to repeated, hard-to-treat infections. The trial will compare the drug against a period without t…
Phase: PHASE3 • Sponsor: AUG Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
Rare immune disorder drug tested for long-term safety in tiny study
Disease control Recruiting nowThis study looks at the long-term safety of a drug called AVTX-803 for people with leukocyte adhesion deficiency type II (LAD II), a rare genetic condition that weakens the immune system. Only 2 participants who completed a previous study can join. Researchers will monitor side e…
Phase: PHASE3 • Sponsor: AUG Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:07 UTC